These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
26 Jun, 2026, 11.31 AM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
17 Jun, 2026, 03.08 PM IST
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
12 Jun, 2026, 12.25 PM IST
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
23 May, 2026, 10.24 PM IST
Dr Reddy's shares jump 5% despite 14% YoY fall in Q3 profit. Should you buy, sell or hold?Dr Reddy's shares: The company posted a 14% year-on-year decline in consolidated net profit to Rs 1,210 crore.
22 Jan, 2026, 09.45 AM IST
Dr Reddy's Laboratories Q3 Results: Profit falls 14% YoY to Rs 1,210 crore, revenue up 4%Dr Reddy’s Laboratories reported a 14% YoY drop in Q3 net profit to Rs 1,210 crore, even as revenue rose 4% to Rs 8,727 crore. Lower margin...
21 Jan, 2026, 05.27 PM IST
Dr Reddy's launches generic OTC ophthalmic solution in US marketDr Reddy's Laboratories has launched a new eye drop in the United States. This over-the-counter solution treats itchy eyes. It is an antihi...
14 Jan, 2026, 10.51 PM IST
Stocks in news: Angel One, Tata Steel, Shriram Finance, IndiGo, EternalMarkets extended their corrective phase on Wednesday, with the Nifty nearing support levels. Several companies are in focus today due to si...
08 Jan, 2026, 06.40 AM IST
Glenmark arm recalls products in US for manufacturing issuesGlenmark Pharmaceuticals is recalling 45,504 bottles of Ryaltris Nasal Spray and 11,568 tubes of Ciclopirox Gel in the US due to manufactur...
13 Oct, 2024, 12.21 PM IST
Glenmark's partner Hikma launches specialty drug Ryaltris in USRyaltris is the only fixed-dose combination of olopatadine hydrochloride and mometasone furoate approved by the USFDA for the treatment of ...
30 Aug, 2022, 07.21 PM IST
Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US"The over-the-counter market has long been an important segment of Glenmark's portfolio around the world. Our acquisition of these ANDAs re...
28 Jun, 2022, 12.13 PM IST
Dr Reddy's Laboratories launches over-the-counter eye allergy drop in USDr Reddy's said Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2 per cent and 0.1 per cent, are indicated for the temporary relief of...
17 Sep, 2020, 12.29 PM IST
Glenmark Pharma says USFDA has issued CRL for RyaltrisThe CRL cites deficiencies in the Drug Master File pertaining to one of the active pharmaceutical ingredients and in manufacturing faciliti...
22 Jun, 2019, 03.49 PM IST
Alembic Pharmaceuticals gets USFDA nod for ophthalmic solutionThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride ophthalmic solut...
10 Dec, 2018, 12.14 PM IST
Aurobindo Pharma gets USFDA nod for its conjunctivitis drugAurobindo Pharma has received approval from the USFDA nod for generic Olopatadine Hydrochloride ophthalmic solution used for treatment of c...
22 Dec, 2015, 01.13 PM IST
- Wockhardt gets USFDA nod for generic eye drops
Drug maker Wockhardt said it has received tentative approval from the US health regulator to market Olopatadine hydrochloride eye drops in ...
02 Jul, 2011, 04.42 AM IST
- Wockhardt receives USFDA approval for generic eye drops
Drug maker Wockhardt today said it has received tentative approval from the US health regulator.
01 Jul, 2011, 02.11 PM IST